OPEN Health’s Beth Lesher, PharmD, BCPS, has been invited to serve a second term on the Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions Committee, which issues highly influential guidance on AMCP dossiers. AMCP dossiers are widely used by healthcare decision-makers in evaluating medical products in the United States.
The invitation to Lesher, a senior director in the Strategic Market Access Center of Excellence, testifies to her specialist expertise, and, by extension, OPEN Health’s, in a critical HEOR and Market Access function.
“For the past 20+ years, I have worked on developing and updating AMCP dossiers for our clients,” says Lesher. Serving as a member on the format committee, she says, allows her to apply that experience to updating and improving the AMCP format guidance document.
Formally called the Format for Formulary Submissions Guidance on Submission of Pre-approval and Post-approval Clinical and Economic Information and Evidence, it “supports the informed review, assessment, selection, and payment of medical products,” according to the AMCP website. Although AMCP formatting is not required in submissions, it is considered the standard.
The last update to the format was in December 2019; that was version 4.1, Lesher says. The next update will be the first since the AMCP issued guidelines for unapproved product dossiers, approved product dossiers, and unapproved use dossiers.
Her term on the committee will extend to the AMCP annual meeting in 2025.
“Beth’s reappointment to the AMCP committee is a testament to her expertise in this area. She is an invaluable resource for our clients and team members, and OPEN Health is lucky to have the benefit of her leadership,” says Dipen Patel, vice president and executive director of OPEN Health Evidence & Access.
